---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-095464"
form_type: "8-K"
ticker: "COLL"
cik: "0001267565"
company_name: "COLLEGIUM PHARMACEUTICAL, INC"
filed_at: "2026-08-13T11:30:31+00:00"
generated_at: "2026-08-13T11:35:21.601495+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Collegium enters $50M accelerated share repurchase with Jefferies

## Summary
- ASR agreement with Jefferies LLC to repurchase $50M of common stock, announced Aug 12, 2026.
- Initial delivery of 1,556,420 shares at $25.70 closing price (Aug 12, 2026), ~80% of expected total.
- Part of $150M buyback program authorized July 2025; final settlement expected by Q4 2026.
- Final share count based on VWAP during term; ~32.5M shares outstanding as of June 30, 2026.

## SEC filing metadata
- accession: 0001104659-26-095464
- form_type: 8-K
- ticker: COLL
- cik: 0001267565
- company_name: COLLEGIUM PHARMACEUTICAL, INC
- filed_at: 2026-08-13T11:30:31+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1267565/000110465926095464/0001104659-26-095464-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1267565/000110465926095464/tm2623090d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-095464
- JSON: https://secwatch.observer/filing/0001104659-26-095464.json
- Plain text: https://secwatch.observer/filing/0001104659-26-095464.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.